Genetic Cancer Risk
Showing 9976 - 10000 of >10,000
Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)
Active, not recruiting
- Breast Cancer
- Ribociclib
- +3 more
-
Casale Monferrato, AL, Italy
- +40 more
Dec 3, 2021
Clinician Assessment of Patient Dyspnea
Recruiting
- Dyspnea
-
Chicago, IllinoisRush University Medical Center
Apr 25, 2022
Efficacy in Randomized Controlled Trials in Elderly Cancer
Active, not recruiting
- Cancer
- Elderly cancer patients
-
Bordeaux, FranceInstitut Bergonié
Feb 2, 2022
MiRNA in Detecting Active Germ Cell Tumors in Early Suspected
Recruiting
- Malignant Testicular Germ Cell Tumor
- Non-Interventional Study
-
Los Angeles, California
- +1 more
Sep 28, 2023
Breast Cancer Trial in China (AI adjuvant therapy, AI+chemo adjuvant therapy)
Active, not recruiting
- Breast Cancer
- AI adjuvant therapy
- AI+chemotherapy adjuvant therapy
-
Beijing, Beijing, China
- +13 more
Nov 26, 2021
Cognitive Decline, Cognitive Impairment, Mild, Aging Trial in Seoul (mobile-based, paper-based)
Completed
- Cognitive Decline
- +3 more
- mobile-based
- paper-based
-
Seoul, Korea, Republic ofSilviahealth
Jan 5, 2023
Mucositis Trial in Des Moines (SBI, Placebo)
Terminated
- Mucositis
- SBI
- Placebo
-
Des Moines, IowaMercyOne Des Moines Medical Center
Jan 24, 2023
Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Worldwide (drug, biological, radiation)
Recruiting
- Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Cyclophosphamide
- +12 more
-
Birmingham, Alabama
- +187 more
Jan 31, 2023
Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)
Not yet recruiting
- Pancreas Cancer
- +5 more
- Laparoscopic surgical biopsy and organoid generation
- (no location specified)
Apr 22, 2022
Esophageal Cancer Trial in Cologne, Utrecht (Laparoscopic ischemic conditioning followed by esophagectomy)
Recruiting
- Esophageal Cancer
- Laparoscopic ischemic conditioning followed by esophagectomy
-
Cologne, North Rhine-Westphalia, Germany
- +1 more
Jan 11, 2022
Metastatic Renal Cell Carcinoma Trial in France (PRISM care program)
Recruiting
- Metastatic Renal Cell Carcinoma
- PRISM care program
-
Angers, France
- +11 more
Apr 22, 2022
Gestational Diabetes Trial (Mobile instant messaging-based lifestyle intervention, Text messaging reminders, Brief advice on GDM
Not yet recruiting
- Gestational Diabetes
- Mobile instant messaging-based lifestyle intervention
- +3 more
- (no location specified)
Sep 28, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Imatinib 400 MG Oral Tablet
-
Gothenburg, SwedenBarbro Linderholm
Feb 1, 2023
Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)
Completed
- Early Stage Breast Cancer
-
Boston, Massachusetts
- +3 more
Apr 11, 2022
Bereavement Trial in Brooklyn (Vocal Expression, Cognitive Behavioral)
Not yet recruiting
- Bereavement
- Vocal Expression
- Cognitive Behavioral
-
Brooklyn, New YorkSouth Brooklyn Health
Apr 21, 2023
Radiomic fEatures of Pancreas From Contrast Enhanced CT Image
Not yet recruiting
- Pancreatitis, Chronic
- Radiomics Model
- (no location specified)
Mar 20, 2023
Paget's Disease: Long Term Extension
Recruiting
- Paget Disease
-
Geelong, Australia
- +20 more
Mar 11, 2022
Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial in Seattle (Counseling, Psilocybin,
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Metastatic Malignant Solid Neoplasm
- Counseling
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 5, 2023
Prostate Cancer, Psychosocial Stressor Trial (WINGS-IP1 Smartphone Application)
Not yet recruiting
- Prostate Cancer
- Psychosocial Stressor
- WINGS-IP1 Smartphone Application
- (no location specified)
Feb 7, 2023
Breast Cancer Trial (SHR-A1811, Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel)
Not yet recruiting
- Breast Cancer
- (no location specified)
Apr 3, 2023
Does Cerebroplacental Ratio Predict Adverse Outcomes in Low Risk
Terminated
- Cerebroplacental Ratio
-
New Brunswick, New Jersey
- +5 more
Jan 16, 2023
The Natural History of Metachromatic Leukodystrophy
Recruiting
- MLD
- +26 more
- Palliative Care
- Hematopoetic Stem Cell Transplantation
-
Pittsburgh, PennsylvaniaThe Program for the Study of Neurodevelopment in Rare Disorders,
Nov 2, 2021
Healthcare Resource Utilisation, Common Mental Health Problems,
Completed
- Inflammatory Bowel Diseases
- +2 more
- No intervention
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Childhood Cancer Trial in Kirikkale (Technology Based Motivation Program)
Completed
- Childhood Cancer
- Technology Based Motivation Program
-
Kırıkkale, TurkeyZeynep Kisecik Şengül
Aug 1, 2023